Core Viewpoint - Jianxin Superconducting (688805) has been listed on the Shanghai Stock Exchange, focusing on the research, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment [1][2]. Company Overview - Jianxin Superconducting primarily engages in the development, production, and sales of key components for MRI equipment, including superconducting magnets, permanent magnets, and gradient coils, which account for approximately 50% of the cost of MRI equipment [2]. - The controlling shareholders are Xu Jianyi, Xu Hui, and Xu Dianbo, with a combined voting power of 59.92% prior to the issuance. After the issuance, their combined voting power will decrease to 44.94% [2]. Financial Information - The total amount raised from the issuance is 778.8736 million yuan, with a net amount of 688.6427 million yuan after deducting issuance costs. The funds will be used for projects including the annual production of 600 sets of liquid helium-free superconducting magnets, annual production of 600 sets of high-field medical superconducting magnets, and the research and development of new superconducting magnets [2].

12月24日消息，交易所公告称，健信超导今日在上交所科创板上市，公司证券代码：688805，发行市盈 率为61.97倍。新广益、陕西旅游中签号出炉，网上发行中签号分别有30085个、38666个。 【今日上市】 健信超导今日上市 发行价格18.58元/股 据交易所公告，健信超导今日在上交所科创板上市，公司证券代码：688805，发行价格18.58元/股，发 行市盈率为61.97倍。 公司简介： 2013年12月11日,公司前身宁波凯方核磁技术有限公司成立。 2015年10月,公司名称由"宁波 凯方核磁技术有限公司"变更为"宁波健信核磁技术有限公司"。 2022年11月3日,公司名称变更为"宁波健 信超导科技股份有限公司" 主营业务：医用磁共振成像(MRI)设备核心部件的研发、生产和销售。 【中签号及缴款】 新广益中签号出炉 共计30085个 末"五"位数：66979，06979，26979，46979，86979； 末"六"位数：980369，180369，380369，580369，780369，402156； 末"八"位数：60461731，00461731，20461731，40461731，80461 ...

Market Overview - On December 23, 2025, the A-share market saw all three major indices close higher, with the Shanghai Composite Index at 3919.98 points, up 0.07%, the Shenzhen Component Index at 13368.99 points, up 0.27%, and the ChiNext Index at 3205.01 points, up 0.41%. However, the overall market had more decliners than gainers, with over 3800 stocks declining. The total trading volume in the Shanghai and Shenzhen markets was 1.90 trillion yuan, an increase of 37.9 billion yuan from the previous trading day [1] - In the Hong Kong market, all three major indices turned negative, with the Hang Seng Index down 0.11% or 27.63 points, closing at 25774.14 points, and a total trading volume of 157.13 billion HKD. The Hang Seng China Enterprises Index fell 0.29% to 8913.83 points, while the Hang Seng Tech Index decreased by 0.69% to 5488.89 points [1] - In the U.S. market, the three major indices had mixed results, with the Dow Jones Industrial Average up 0.61% to 47716.42 points, the S&P 500 up 0.54% to 6849.09 points, and the Nasdaq Composite up 0.65% to 23365.69 points [1] New Stock Listing - The new stock "Jianxin Superconductor" listed on the Sci-Tech Innovation Board with a stock code of 688805, priced at 18.58 yuan per share and a price-to-earnings ratio of 61.97 times. The company is a leading player in the core components of medical magnetic resonance imaging (MRI) equipment, focusing on the R&D, production, and sales of superconducting magnets, permanent magnets, and gradient coils. It has established a comprehensive product matrix in the superconducting field, becoming the world's top independent supplier of superconducting magnets in the MRI industry [2] Important News - The Guangxi Futures Exchange announced adjustments to the trading fee standards, price fluctuation limits, and margin standards for platinum, palladium, and lithium carbonate futures contracts, effective from December 25, 2025. The trading fee for platinum and palladium futures will be adjusted to 0.025% of the transaction amount, while the fee for lithium carbonate futures will be set at 0.032%. The price fluctuation limit for platinum and palladium futures will be adjusted to 10%, with a margin requirement of 12% [3] - The sixth batch of national high-value medical consumables procurement has officially started, focusing on drug-coated balloons and urological intervention consumables, with bids opening on January 13, 2026. This round of procurement introduces two new features: the concept of anchor pricing and a multi-revival mechanism. The anchor pricing aims to balance price reduction and prevent malicious underpricing, helping to avoid excessive competition and collusion among companies [4]

Core Viewpoint - The company emphasizes that hard technology entrepreneurship is both a technological and a long-term battle, requiring a steadfast commitment to innovation and market needs to achieve high-quality development in the industry [1][2] Group 1: Company Strategy and Vision - The company aims to focus on technological innovation as the core driving force and market demand as the guiding principle for its development in the medical health sector [2] - The chairman highlights the importance of maintaining a long-term perspective and staying true to the company's original mission in navigating industry cycles [1] Group 2: Technological Advancements - The company has achieved significant breakthroughs in core components of MRI equipment, including superconducting magnets and permanent magnets, becoming a leading manufacturer in China and the largest global supplier of MRI permanent magnets [1] - The company has developed a diverse product matrix, including 1.5T and 3.0T superconducting magnets, and has secured 13 core technologies with independent intellectual property rights [1] Group 3: Market Position and Growth - The company has established deep collaborations with leading manufacturers in the domestic market, ensuring stable supply of 1.5T products and gradually increasing the supply of 3.0T products to rural hospitals [1] - Over 50% of the company's MRI equipment products are sold to overseas markets, with ongoing efforts to build localized service networks in international markets [1] Group 4: Future Outlook - The company plans to continue its dual focus on domestic and international markets, leveraging its global layout to empower downstream MRI equipment manufacturers in expanding overseas [1] - The company is committed to exploring the feasibility of applying superconducting technology in industrial fields such as wind power generation and power transmission [1]

Group 1 - The company Shaanxi Tourism is a leading tourism destination enterprise in Shaanxi Province, focusing on unique attractions such as Huaqing Palace and Mount Huashan [2] - The company has developed tourism performances like "The Song of Everlasting Regret" and "12.12 Xi'an Incident Song," which serve as cultural tourism icons for Shaanxi [2] - The total market capitalization of Shaanxi Tourism is 4.666 billion yuan, with an issuance price of 80.44 yuan and a price-to-earnings ratio of 12.37 [2] Group 2 - The company Jianxin Superconducting, listed on the Sci-Tech Innovation Board, specializes in medical MRI equipment, particularly superconducting magnets and gradient coils [5] - Jianxin Superconducting has become the largest supplier of MRI superconducting magnets globally, breaking the long-standing monopoly of European, American, and Japanese manufacturers [5] - The total market capitalization of Jianxin Superconducting is 2.337 billion yuan, with an issuance price of 18.58 yuan and a price-to-earnings ratio of 61.97 [5]

每经AI快讯，12月24日，今日无新股申购；有1只新股上市，为科创板的健信超导。 ...

Group 1 - The core viewpoint of the article is the listing of a new stock, Jianxin Superconductor, on the Shanghai Stock Exchange's Sci-Tech Innovation Board [1] - Jianxin Superconductor's IPO price is set at 18.58 yuan per share, with an issuance price-to-earnings ratio of 61.97 times [1] - The company has issued a total of 41.92 million shares, with 13.41 million shares available for online subscription [1] Group 2 - The main business of Jianxin Superconductor involves the research, development, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment [1]

| 股票代码 | 688805 | 股票简称 | 健信超导 | | --- | --- | --- | --- | | 申购代码 | 787805 | 上市地点 | 上海证券交易所科创板 | | 发行价格(元/股) | 18.58 | 友行市盈率 | 61.97 | | 市盈率参考行业 | 美用设备制造业 | 参考行业市盈率(最新) | 37.19 | | 发行面值(元) | 1 | 实际募集资金总额(亿 元) | 7.79 | | 网上发行日期 | 2025-12-15 (周一) | 网下配售日期 | 2025-12-15 | | 网上发行数量(股) | 10.060.500 | 网下配書数量(股) | 23.475.500 | | 老股转让数量(股) | | 总发行数量(股) | 41.920.000 | | 申购数量上限(股) | 10.000 | 中签数款目期 | 2025-12-17(周三) | | 网上顶格申购需配市值 (万元) | 10.00 | 网上申购市值确认日 | T-2 日(T:网上申购日) | | 网下申购需配市值(万 元) | 1000.00 | 网下申购市值确认目 | 2025-1 ...

健信超导公告称，本次发行股份数量为4192.00万股，最终战略配售数量为838.40万股，占发行总量的 20.00%。发行价格为18.58元/股，网上初始发行1006.05万股。网上有效申购户数为638.52万户，有效申 购股数为55.50亿股，初步中签率为0.0181%。因网上初步有效申购倍数超100倍，启动回拨机制， 335.40万股从网下回拨到网上。回拨后，网上最终发行1341.45万股，最终中签率为0.0242%。2025年12 月17日（T+2日）投资者需履行缴款义务。 ...

格隆汇12月24日｜今日健信超导(688805.SH)上市，无新股申购。 ...